A phase-IV randomised, double blind comparative evaluation of immunogenicity of monovalent type 1 oral poliomyelitis vaccine (mOPV1) versus trivalent OPV (tOPV): four-armed study
Latest Information Update: 03 Oct 2012
At a glance
- Drugs Poliovirus vaccine live oral (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 02 Jun 2011 Results published in Vaccine.
- 13 Sep 2007 New trial record.